Recruiting studies: Primary Hypercholesterolaemia And Mixed Dyslipidemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib
Phase N/A · 1 location(s) · Boryung Pharmaceutical Co., Ltd · NCT06314919 Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
Phase 3 · 1 location(s) · Shanghai Junshi Bioscience Co., Ltd. · NCT05621070 A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholes
Phase 3 · 2 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07421297 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · 163 location(s) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipide
Phase 3 · 1 location(s) · A. Menarini International Licensing S.A. · NCT07614958 A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Phase 3 · 18 location(s) · Hasten Biopharmaceutical Co., Ltd. · NCT06568471

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.